Retatrutide is a weight loss drug that targets three hormone pathways instead of one or two
Dan Follow me on social media for regular updates @TheOfficialDrDan Subscribe to my newsletter for a heads-up on all new content
Variants in GLP1R , the direct biological target, and MC4R , central to satiety and energy balance, describe part of the terrain the compound acts on
While most of the scientific data comes from dietary studies rather than patch-based use, its inclusion aligns with the product's goal of stabilizing hunger signals
Currently, only a minority of state Medicaid programs cover GLP-1s indicated for chronic weight management, but the landscape is fluid as Medicaid decision makers attempt to strike a balance between expanding treatment options for obesity and state budget limitations
Risk of suicidality with GLP-1 drugs